Reduced nitric oxide levels in acromegaly: Cardiovascular implications

Blood Pressure

Volumn 14, Issue 4, 2005, Pages 227-232

  Ronconi, Vanessa ^a   Giacchetti, Gilberta ^a   Mariniello, Barbara ^b   Camilletti, Andrea ^a   Mantero, Franco ^b   Boscaro, Marco ^a   Vignini, Arianna ^a   Mazzanti, Laura ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Acromegaly; Cardiovascular; Nitric oxide; NO

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GROWTH HORMONE; LIPOXYGENASE; NITRIC OXIDE; SOMATOMEDIN C;

ACROMEGALY; ARTICLE; CARDIOVASCULAR DISEASE; CELL LYSATE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; ENDOTHELIUM; ENZYME ACTIVITY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SUPERNATANT; THROMBOCYTE; THROMBOCYTE AGGREGATION; VASCULAR RESISTANCE; WESTERN BLOTTING;

ACROMEGALY; BLOTTING, WESTERN; CARDIOVASCULAR SYSTEM; CASE-CONTROL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POSTMENOPAUSE;

EID: 25844458249     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050510034293     Document Type: Article

References (32)

1. Brevetti G, Marzullo P, Silvestro A, Pivonello R, Oliva G, Di Somma C, et al. Early vascular alterations in acromegaly. J Clin Endocrinol Metab. 2002;87:3174-3179.
2. Melmed S. Acromegaly. N Engl J Med. 1990;322:966-977.
3. Colao A, Marzullo P, Di Somma C, Lombardi G. Growth hormone and the heart. Clin Endocrinol. 2001;54:137-154.
4. Colao A, Spiezia S, Cerbone G, Pivonello R, Marzullo P, Ferone D, et al. Increased arterial intima-media thickness by B-M mode echo-doppler ultrasonography in acromegaly. Clin Endocrinol. 2001;54:515-524.
5. Rizzoni D, Porteri E, Giustina. A, De Ciuceis C, Sleiman I, Baori GEM, et al. Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Hypertension. 2004;43:1-5.
6. Ignarro LJ. Physiology and pathophysiology of nitric oxide. Kidney Int. 1996;55:S2-S5.
7. Camilletti A, Moretti N, Giacchetti G, Faloia E, Martarelli D, Mantero F, et al. Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients. Am J Hypertens. 2001;14:382-386.
8. Rabini RA, Staffolani R, Martarelli D, Fumelli P, Ravaglia F, Dousset N, et al. Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions. J Clin Endocrinol Metab. 1999;84:3770-3774.
9. Cuticca CM, Giusti M, Bocca L, Sessarego P, De Martini D, Valenti S, et al. Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly. Neuroendocr. 1997;66:426-431.
10. Capaldo B, Guardasole V, Pardo F, Matarazzo M, Di Rella F, Numis F, et al. Abnormal vascular reactivity in growth hormone deficiency. Circulation. 2001;103:520-524.
11. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 1992;340:1188-1192.
12. Boger RH, Skamira C, Bode Boger SM, Brabant G, Von zur Muhlen A, Frolich JC. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo controlled study. J Clin Invest. 1996;98:2706-2713.
13. Pfeifer M, Verhover R, Zizek B, Prezelj J, Poredos P, Clayton RN. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab. 1999;84:453-457.
14. Rosen T, Bengtsson B. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990; 336:285-288.
15. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol. 1996;46:75-81.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
17. Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M, et al. Insulin sensitivity and regular alcohol consumption: Large, prospective, cross sectional population study (Bruneck study). BMJ. 1996;313:1040-1044.
18. Chen LY, Media P, Media JL. Oxidized LDL decreases L-arginine uptake and oxide synthase protein expression in human platelets. Circulation. 1996;93:1740-1746.
19. Lowry OH, Rosenbrough A, Farr AL, Randal RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
20. Tannous M, Rabini RA, Vignini A, Moretti N, Fumelli P, Ielinski B, et al. Evidence for NOS-dependent peroxynitrite production in diabetic platelets. Diabetologia. 1999; 42:539-544.
21. Colao AM, Marzullo P, Cuocolo A, Spinelli I, Pivonello R, Bonaduce D, et al. Reversal of acromegalic cardiomyopathy in young but not middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide. Clin Endocrinol. 2003;58:169-176.
22. Schiavon F, Maffei P, Martini C, De Carlo E, Fais C, Todesco S, et al. Morphologic study of microcirculation in acromegaly by capillaroscopy. J Clin Endocrinol Metab. 1999;84:3151-3155.
23. Isenovic ER, Divald A, Milivojevic N, Grgurevic T, Fisher SE, Sowers JR. Interactive effects of insulin-like growth factor-1 and beta-estradiol on endothelial nitric oxide synthase activity in rat aortic endothelial cells. Metabolism. 2003;52:482-487.
24. Spieker LE, Sudano I, Hurlimann D, Lerch PG, Lang MG, Binggeli C, et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation. 2002;105:1399-1402.
25. Lundman P, Eriksson MJ, Stuhlinger M, Cooke JP, Hamsten A, Tornvall P. Mild-to-moderate hypertriglyceridaemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol. 2001;38:111-116.
26. De la Pena-Diaz A, Izaguirre-Avila R, Angles-Cano E. Lipoprotein Lp(a) and atherothrombotic disease. Arch Med Res. 2000;31:353-359.
27. Arosio M, Sartore G, Rossi CM, Casati G, Faglia G, Manzato E. LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy. Italian Multicentre Octreotide Study Group. Atherosclerosis. 2000;151:551-557.
28. Moeslinger T, Friedl R, Volf I, Brunner M, Koller E, Spieckermann PG. Inhibition of inducible nitric oxide synthesis by oxidized lipoprotein (a) in a murine macrophage cell line. FEBS Lett. 2000;478:95-99.
29. Tan KCB, Shiu SWM, Janus ED, Lam KSL. LDL subfractions in acromegaly: Relation to growth hormone and insulin-like growth factor-I. Atherosclerosis. 1997; 129:59-65.
30. Taddei S, Virdis A, Mattei P, Natali A, Ferrarini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation. 1995;92:2911-2918.
31. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation. 1996;93:1331-1333.
32. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894-898.